Drawing from the observation that BCN1369 also exhibited elevated PI3K-Akt-mTOR signaling (Fig. 5b), together with a recent report that showed mTOR mediated MUC1 induction in multiple breast cancer cell lines30, these PDX models were additionally treated with the small molecule mTOR inhibitor everolimus. The gene discussed is MUC1; the disease is breast cancer.